Re:search – The Hidden Risks of Long-Term Proton Pump Inhibitor (PPI) Use: A Call for Root-Cause Solutions
Written by Paula Owen
Expert Review By KBS Research Team
Rebound Hyperacidity
Upon withdrawal of PPIs, patients often experience rebound acid hypersecretion, a transient surge in acid production that can intensify symptoms (1). This creates a dependency loop, making long-term discontinuation challenging.
Nutrient Deficiencies
Prolonged PPI use has been linked to malabsorption of vitamin B12, calcium, magnesium, and iron (2,3). These deficiencies may contribute to anemia, bone fractures, and neurological dysfunction.
Cognitive Decline
Several population-based studies have suggested a correlation between long-term PPI use and increased risk of dementia, with proposed mechanisms including vitamin B12 deficiency and altered central nervous system pH (4,5).
Kidney and Cardiovascular Risk
Long-term use of PPIs has also been associated with chronic kidney disease, acute interstitial nephritis, and increased cardiovascular risk (6,7).
Microbiome Disruption
PPIs alter the gut’s natural acid barrier, increasing susceptibility to infections such as Clostridium difficile and promoting small intestinal bacterial overgrowth (SIBO) (8).
Gastric Atrophy and Hypergastrinemia
Acid suppression can lead to compensatory hypergastrinemia and changes in the gastric mucosa, including fundic gland polyps and atrophic gastritis (9).
Drug Interactions
By affecting cytochrome P450 enzymes, PPIs can interfere with the metabolism of common medications, including clopidogrel, warfarin, and certain antifungals (10).
Discussion
While PPIs remain appropriate for acute symptom relief and healing of esophageal erosions, their long-term use should be reconsidered. Many symptoms attributed to acid excess are better understood as dysfunctions of motility, mucosal protection, or esophageal sphincter tone.
Conclusion
The rising concerns around chronic PPI use highlight the need for safer, more holistic approaches. Emerging therapies—such as polyphenol-based combinations that support motility, sphincter function, and mucosal healing—offer a promising path forward. A shift toward root-cause resolution, rather than perpetual suppression, may benefit millions.